ZELLBRIDGE VANDEFITEMCEL
LIVE

Serial Number

79295147

Owner

SanBio Company Limited

Attorney

N. Alexander Nolte

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZELLBRIDGE VANDEFITEMCEL Trademark

Serial Number: 79295147 • Registration: 6714877

ZELLBRIDGE VANDEFITEMCEL is a trademark filed by SanBio Company Limited on August 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SanBio Company Limited (8 trademarks)

8-1, Akashi-Cho

Entity Type: 03

Trademark Details

Filing Date

August 3, 2020

Registration Date

May 3, 2022

Published for Opposition

February 15, 2022

Goods & Services

Stem cells for medical and veterinary purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; all the aforementioned being vandefitemcel that are stem cells affecting fibroblasts for use during cell therapy

Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular grafts

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 2, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 2, 2022 FIMP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 2, 2022 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Aug 15, 2022 LIMG
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
May 3, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 26, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2022 OPNR
NOTIFICATION PROCESSED BY IB
Feb 20, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 26, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 26, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 5, 2022 TROA
REFUSAL PROCESSED BY IB
Aug 15, 2021 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 17, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2020 REPR